Previous 10 | Next 10 |
Shares of the recombinant-protein vaccine specialist Novavax (NASDAQ: NVAX) were down by a noteworthy 9.2% on heavy volume as of 9:55 a.m. ET on Thursday. As a result, the biotech's stock price hit a fresh 52-week low this morning. What's weighing on Novavax's shares today? ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Tada Images/ShutterStock.com Accenture (NYSE: ACN ) stock is on the move Thursday after releasing earnings and announcing an acquisition. Starting with earnings, the company reported diluted earnings ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Willy Barton / Shutterstock.com Spero Therapeutics (NASDAQ: SPRO ) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (NYSE: GSK ). This deal covers the...
Novavax ( NASDAQ: NVAX ) shares dropped ~6% in the pre-market trading Thursday after JPMorgan downgraded the Maryland-based COVID-19 vaccine maker to Underweight from Neutral, citing, among other things, the company’s long-term outlook. In addition to an updated m...
As a company, if the need for your latest and highest-profile product is declining rapidly, some investors are likely to bail. That dynamic was very much in force with Novavax (NASDAQ: NVAX) stock on Monday, and to a lesser extent with its healthcare industry peer Johnson &...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s a mixed day for the stock market, but it’s not a good day for vaccine stocks. Across the board, these names are getting sold. Pfizer (NYSE: PFE ) is down 2%, while Moderna (NASDAQ: MRNA ) is...
Novavax ( NASDAQ: NVAX ) announced Friday that the Israel Ministry of Health greenlighted the use of its COVID-19 vaccine Nuvaxovid in those aged 12 years and above for immunization against coronavirus disease. The import and use permit issued by the ministry allows the us...
Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization in Taiwan for Use in Adolescents Aged 12 Through 17 PR Newswire GAITHERSBURG, Md. , Sept. 16, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology ...
Novavax Nuvaxovid™ COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older PR Newswire The Israeli Advisory Committee on Epidemics has recommended that Nuvaxovid™ be approved for ages 12 and older as a primary series and as a heterolo...
Novavax, Inc. (NVAX) Baird 2022 Global Healthcare Conference Call September 13, 2022 08:30 ET Company Participants Gregory Glenn - President, R&D John Trizzino - Chief Commercial Officer and Chief Business Officer Presentation Unidentified Analyst ...
News, Short Squeeze, Breakout and More Instantly...
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 5.74% on an annualized basis producing an average annual return of 18.97...
Novavax to Participate in 2024 Jefferies Global Healthcare Conference PR Newswire GAITHERSBURG, Md. , May 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today annou...
U.S. stock futures were lower this morning, with the Dow futures falling around 150 points on Wednesday. Shares of American Airlines Group Inc. (NA...